-+ 0.00%
-+ 0.00%
-+ 0.00%

Corvus Pharmaceuticals to Announce Phase 1 Soquelitinib Atopic Dermatitis Trial Results in January 2026

Reuters·01/05/2026 13:31:01

Please log in to view news